Common Contracts
1 similar Clinical Trial Agreement contracts
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ Effective Date: the date of publication of the contract in the register of contracts Datum účinnosti: dnem uveřejnění smlouvy v registru smluv Sponsor Incyte Corporation located at 1801 Augustine...Clinical Trial Agreement • December 17th, 2021
Safety of Tafasitamab plus Lenalidomide in Addition to Rituximab versus Lenalidomide in Addition to Rituximab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma tafasitamabu plus lenalidomidu v kombinaci s rituximabem ve srovnání s lenalidomidem v kombinaci s rituximabem u pacientů s relabujícím/refrakterním (R/R) folikulárním lymfomem stupně 1 až 3a nebo R/R lymfomem z marginální zóny THIS CLINICAL TRIAL AGREEMENT (the“Agreement”), effective as of the date of publication of the contract in the register of contracts (“Effective Date”), is entered among Syneos Health UK Limited, with principal offices located in the United Kingdom at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, United Kingdom, including its affiliates, subsidiaries, and specifically its parent company Syneos Health, LLC (“CRO”) acting in its own name and for and on behalf of and in the name of Incyte Corporation located
